Abstract Library

#4193 Pivotal role of the multidisciplinary tumor board on the management of neuroendocrine neoplasms – Impact of MTB decisions in an ENETS Center of Excellence

Introduction: Multidisciplinary Tumor Board (MTB) meetings are a valuable tool to improve the management of solid tumors. Yet, few evidences regarding the real-world impact of Neuroendocrine Neoplasm (NEN)-dedicated MTBs are available.

Conference:

Presenting Author:

Authors: Maratta M, Vitale A, Occhipinti D, Raia S, Menotti S,

Keywords: multidisciplinary tumor board, neuroendocrine cancer, disease management, patient care,

#4121 The efficacy and safety analysis of transarterial embolisation in the treatment of cystic neuroendocrine neoplasm liver metastasis

Introduction: Liver metastases are common in neuroendocrine neoplasm (NEN). Cystic NEN liver metastases (cNENLM) are rare, and the efficacy of transarterial embolization (TAE) has not been reported.

Conference:

Presenting Author:

Authors: Yu H, Wang Y, Zhang N, Liu H, Chen L,

Keywords: Transaterial embolization, Neuroendocrine neoplasm, Liver metastasis, Cystic, Efficacy, Safety,

#3569 Outcomes of Streptozotocin (STZ)-based chemotherapy (CT) in patients with advanced pancreatic neuroendocrine tumors (pNETs): Data from the Spanish Taskforce of Neuroendocrine and Endocrine Tumors (GETNE) national registry (R-GETNE)

Introduction: STZ-based CT has been used for advanced pNETs with rapid growth, high tumor load or progression to somatostatin analogues (SSA). Evidence supporting use of STZ-based CT in pNET is mainly retrospective, and there is an unmet need of prospective trials in this setting. We present data from the R-GETNE regarding the use of STZ in spanish centers.

Conference:

Presenting Author:

Authors: Esteban-Villarrubia J, Hernando J, Garcia A, Jimenez-Fonseca P, Teulé A,

Keywords: Streptozotocin, Chemotherapy, pNET, GETNE, R-GETNE,

#3370 Finding the outcomes of NEN managed by high dose radiations in Pakistan

Introduction: Considering the oncologic control for aggressive neuroendocrine neoplasm, external beam radiation therapy provides a non-invasive method to safely deliver local therapy to nearly any location in the body.

Conference:

Presenting Author: Fatima A

Authors: Fatima A,

Keywords: external beam radiation, local control, metastasis, solid tumor,

#3229 The use of deep learning models to predict progression-free survival in patients with neuroendocrine tumors: Results from phase 3 of the RAISE project

Introduction: Response Evaluation Criteria in Solid Tumors (RECIST) assesses treatment response via tumor progression in patients with neuroendocrine tumors (NET). RAISE combined deep learning models (DLM) with sum of the longest diameter (SLD) of liver lesions and chromogranin A (CgA) to find a surrogate endpoint for RECIST to early predict progression-free survival (PFS).

Conference: 18th Annual ENETS Concerence (2021)

Presenting Author: Pavel M

Authors: Pavel M, Dromain C, Ronot M, Schaefer N, Mandair D,

Keywords: neuroendocrine tumor, deep learning models, progression-free survival, prediction,